Xcout IntelCollimateHealth
CollimateHealth is a Munich-based oncology technology startup and life sciences company. It is developing a clinically scalable microbeam radiation technology for oncological treatment, aiming to transform radiation therapy into an immunotherapy. The company recently closed an oversubscribed €6 million seed round.
Subscribe to see CollimateHealth’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CollimateHealth at a glance
CollimateHealth is a healthcare company headquartered in Germany. Its most recent funding round, Seed, raised $6.6M in June 2026. Xcout tracks 6 named people at CollimateHealth, including Dr. Hans Maria Heÿn (Chief Executive Officer).
CollimateHealth leadership
- Dr. Hans Maria HeÿnChief Executive Officer
- Hans Maria Heÿnco-founder and Chief Executive Officer
- Dr. Johanna WinterChief Technology Officer
- Johanna Winterco-founder and Chief Technology Officer
- Prof. Dr. Stefan BartzschChief Scientific Officer
- Stefan Bartzschfounder
CollimateHealth funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $6.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent CollimateHealth news
Investors
CollimateHealth competitors
A few of CollimateHealth's closest competitors — see the full list of competitors and alternatives →
Clinical Laserthermia Systems develops minimally invasive laser ablation systems and thermal therapy products for use in oncology, urology, and neurosurgery. The company serves healthcare professionals and hospitals by providing tools for precise tissue ablation in treatments such as localized prostate cancer and brain lesions.
SkinCure Oncology provides dermatology practices with comprehensive solutions and support to offer Image-Guided Superficial Radiation Therapy (IG-SRT) for non-melanoma skin cancer. The company equips practices with treatment devices, radiation therapists, and operational support to deliver non-invasive cancer care directly in a clinical setting.
Advanced Particle Therapy develops, builds, and manages proton therapy cancer treatment centers for academic medical institutions and healthcare systems. The company provides turnkey development solutions, including facility design and construction, equipment planning, financing, and operational management.
Leo Cancer Care is a medical technology company headquartered in Crawley, Surrey, focused on improving cancer treatment through upright patient positioning and advanced radiation therapy.
NanoEcho is a medical technology company that develops a diagnostic method for mapping the spread of rectal cancer to lymph nodes. The company's patented technology combines a magnetic field, iron oxide-based nanoparticles, and ultrasound to provide high-resolution imaging and improve treatment planning for healthcare providers.
FluoGuide is a biotechnology company that develops products for precision cancer surgery to improve patient outcomes. Its lead product, FG001, illuminates cancerous tissue during procedures to help surgeons perform more precise operations and reduce cancer recurrence.
Get CollimateHealth's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CollimateHealth in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access